EUVIMEDEUVIMED entdecken
Open Access

CRISPR-based biosensors for human health: A novel strategy to detect emerging infectious diseases

Yawen He, Qinqin Hu, Samantha San, Tom Kasputis, Maria Gabriella Duarte Splinter, Kun Yin, Juhong Chen

TrAC Trends in Analytical Chemistry · 2023-11 · 168 · 117342

DOI: 10.1016/j.trac.2023.117342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TrAC Trends in Analytical Chemistry, 2023-11. Verfasst von Yawen He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Systems Engineering, Virginia Tech, Blacksburg, VA 24061, USA. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, National Institute of Food and Agriculture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infectious diseases (such as sepsis, influenza, and malaria), caused by various pathogenic bacteria and viruses, are widespread across the world. Early and rapid detection of disease-related pathogens is necessary to reduce their spread in the world and prevent their potential global pandemics. The clustered regularly interspaced short palindromic repeats (CRISPR) technology, as the next-generation molecular diagnosis technique, holds immense promise in the detection of infectious diseases because of its remarkable advantages, including supreme flexibility, sensitivity, and specificity. While numerous CRISPR-based biosensors have been developed for application in environmental monitoring, food safety, and point-of-care diagnosis, there remains a critical need to summarize and explore their potential in human health. This review aims to address this gap by focusing on the latest advancements in CRISPR-based biosensors for infectious disease detection. We provide an overview of the current status, pre-amplification methods, the unique feature of each CRISPR system, and the design of CRISPR-based biosensing strategies to detect disease-associated nucleic acids. Last but not least, the review analyzes the current challenges and provides future perspectives, which will contribute to developing more effective CRISPR-based biosensors for human health.

Schlagwörter

Stichwörter der Autor:innen

BiosensorCRISPRCas nucleaseInfectious diseaseNucleic acids

Autor:innen und Institutionen

  • Department of Biological Systems Engineering, Virginia Tech, Blacksburg, VA 24061, USA.
  • School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • One Health Center, Shanghai Jiao Tong University-The University of Edinburgh, Shanghai, People's Republic of China.

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institute of Food and Agriculture

Zitieren

APA

He, Y., Hu, Q., San, S., Kasputis, T., Splinter, M. G. D., Yin, K., & Chen, J. (2023). CRISPR-based biosensors for human health: A novel strategy to detect emerging infectious diseases. TrAC Trends in Analytical Chemistry, 168, 117342. https://doi.org/10.1016/j.trac.2023.117342

Vancouver

He Y, Hu Q, San S, Kasputis T, Splinter MGD, Yin K, et al. CRISPR-based biosensors for human health: A novel strategy to detect emerging infectious diseases. TrAC Trends in Analytical Chemistry. 2023;168:117342. doi:10.1016/j.trac.2023.117342

BibTeX
@article{He2023,
  author = {He, Yawen and Hu, Qinqin and San, Samantha and Kasputis, Tom and Splinter, Maria Gabriella Duarte and Yin, Kun and Chen, Juhong},
  title = {CRISPR-based biosensors for human health: A novel strategy to detect emerging infectious diseases},
  journal = {TrAC Trends in Analytical Chemistry},
  year = {2023},
  volume = {168},
  pages = {117342},
  doi = {10.1016/j.trac.2023.117342}
}
Kostenlos starten →